Bevacizumab promotes venous thromboembolism through the induction of PAI-1 in a mouse xenograft model of human lung carcinoma.

MLA

Chen, Ni, et al. “Bevacizumab Promotes Venous Thromboembolism through the Induction of PAI-1 in a Mouse Xenograft Model of Human Lung Carcinoma.” Molecular Cancer, vol. 14, July 2015, p. 140. EBSCOhost, https://doi.org/10.1186/s12943-015-0418-x.

APA

Chen, N., Ren, M., Li, R., Deng, X., Li, Y., Yan, K., Xiao, L., Yang, Y., Wang, L., Luo, M., Fay, W. P., & Wu, J. (2015). Bevacizumab promotes venous thromboembolism through the induction of PAI-1 in a mouse xenograft model of human lung carcinoma. Molecular Cancer, 14, 140. https://doi.org/10.1186/s12943-015-0418-x

Chicago

Chen, Ni, Meiping Ren, Rong Li, Xin Deng, Yongjie Li, Kai Yan, Lamei Xiao, et al. 2015. “Bevacizumab Promotes Venous Thromboembolism through the Induction of PAI-1 in a Mouse Xenograft Model of Human Lung Carcinoma.” Molecular Cancer 14 (July): 140. doi:10.1186/s12943-015-0418-x.